Discovery of genetic association in response time to diet in irritable bowel syndrome

A new study suggests that genetic differences may account for the different responses people have to diets for the treatment of irritable bowel syndrome (IBS). This finding could help doctors design personalized nutritional treatments for patients with IBS.

According to Tekna Technology Media Health and Medical News Service, irritable bowel syndrome is a chronic disorder that is associated with symptoms such as abdominal pain, bloating, diarrhea, and constipation. One of the common treatment methods for this disease is to change the diet and limit the consumption of certain carbohydrates (FODMAPs). However, this diet is not equally effective for all patients.

The study’s researchers found that changes in genes related to carbohydrate digestion may affect how people respond to a low-FODMAP diet. In other words, people with certain changes in their genes may respond better to this diet. In this study, researchers looked at more than 250 patients with IBS. The results showed that patients with specific changes in genes related to carbohydrate digestion experienced a significant improvement in their symptoms by following a low FODMAP diet. Meanwhile, this improvement was less observed in patients who did not have specific genetic changes.

These findings suggest that genetic information can be used to predict which patients will respond best to a low-FODMAP diet. Using this information, doctors can design personalized nutritional treatments for their patients and help improve their quality of life. This study is an important step towards a better understanding of irritable bowel syndrome and its treatment. By identifying the genetic factors affecting the response to treatment, more targeted and effective treatments can be achieved. To see the latest news, refer to the scientific news page of Tekna Media.